The India drug delivery devices market size is expected to expand at significant CAGR during the forecast period, 2021–2028. Growth of the market is attributed to the increasing funding from government & private organization, rising number of development & research activities, rise in technological advancement, and unhealthy lifestyle.
The delivery of a drug and therapeutic is done by specialized tools from a specific route of administration like drug delivery devices. As part of one & more medical treatments such devices are used.
The Covid-19 pandemic affected the demand and supply of India drug delivery devices market. Lockdown across the globe, supply chain disorders, and oscillating supply of raw materials forced manufacturers to shut down production leading to unfortunate decline in market growth. Launch of vaccines to combat the Covid-19 pandemic is expected to contribute to the market growth over the forecast period.
The report on the India drug delivery devices market includes an assessment of the market, trends, segments, and regional markets. Overview and dynamics have also been included in the report.
Attributes |
Details |
Report Title |
India Drug Delivery Devices Market–Industry Analysis, Growth, Share, Size, Trends, and Forecast |
Base Year |
2020 |
Historic Data |
2018-2019 |
Forecast Period |
2021-2028 |
Segmentation |
Route of Administration (Topical, Injectable, Ocular, and Others), Applications (Infectious diseases, Cardiovascular cancer, Diabetes, and Others), and End-users (Ambulatory Surgical Centres, Hospitals, and Others) |
Country |
India |
Report Coverage |
Company Share, Market Analysis and Size, Competitive Landscape, Growth Factors, and Trends, and Revenue Forecast |
Key Players covered in the Report |
Sun Pharmaceutical Industries Ltd.; Pfizer Inc.; 3M Company; Merck & Co.; GlaxoSmithKline PLC; Bayer AG; F. Hoffmann-La Roche AG; Johnson & Johnson; Novartis AG; and Sarofi |
Based on route of administration, the India drug delivery devices market is divided into topical, injectable, ocular, and others. The topical segment accounts for a key share of the market. Growth of the market is attributed to the rising prevalence of cardiac disease, unhealthy lifestyles, rise in elderly population, and increasing number of treatments. However, the injectable segment is anticipated to expand at a rapid pace during the forecast period due to increasing patient pool and increasing preference for minor invasive surgeries.
Based on applications, the market is fragmented into infectious diseases, cardiovascular cancer, diabetes, and others. The diabetes segment is anticipated to hold the major market share during the forecast period. Growth of the market is attributed to rising population, increasing disposable income, and growing awareness among population. However, the infectious diseases segment is anticipated to expand at a rapid pace during the forecast period due to factors such as international companies attracting many investors, technological innovations in drug delivery devices, and increasing adaptation of stem cell technologies.
On the basis of end-users, the India drug delivery devices market is segmented into ambulatory surgical centres, hospitals, and others. The hospitals segment accounts for a key share of the market. Growth of the market is attributed to penetration of drug delivery devices in market and increasing per capita income. However, the ambulatory surgical centres segment is anticipated to expand at a rapid pace during the forecast period due to factors such as increasing funding from private organizations.
The India drug delivery devices market is anticipated to expand at a high CAGR during the forecast period due to increasing demand for drug delivery devices and rising awareness about health. Growth of the market is attributed to introduction of technological and novel advanced product and smart drug delivery devices for diseases management.
Rapid development in the health sector increased the demand for drug delivery devices in the India. Increasing number of fatal diseases due to changing life style among people is the major factor fueling the market during the forecast period.
Segments Covered in the Report
The India drug delivery devices market has been segmented on the basis of
Route of Administration
Applications
End-users
Country
Key Players
Key players competing in the India drug delivery devices market include Sun Pharmaceutical Industries Ltd.; Pfizer Inc.; 3M Company; Merck & Co.; GlaxoSmithKline PLC; Bayer AG; F. Hoffmann-La Roche AG; Johnson & Johnson; Novartis AG; and Sarofi
Some of these players are using several market strategies such as product launches, partnerships, merger, capacity expansion, collaborations, and acquisitions to enhance their market shares and to generate revenue and raise their production line of the business in the coming years.
Segments Covered in the Report
The India drug delivery devices market has been segmented on the basis of
Route of Administration
Applications
End-users
Country
Key Players
Key players competing in the India drug delivery devices market include Sun Pharmaceutical Industries Ltd.; Pfizer Inc.; 3M Company; Merck & Co.; GlaxoSmithKline PLC; Bayer AG; F. Hoffmann-La Roche AG; Johnson & Johnson; Novartis AG; and Sarofi
Some of these players are using several market strategies such as product launches, partnerships, merger, capacity expansion, collaborations, and acquisitions to enhance their market shares and to generate revenue and raise their production line of the business in the coming years.
Some other reports from this category!